Timing of Adjuvant Chemotherapy After Surgical Resection for Non-small Cell Lung Cancer : A Target Trial Emulation Using Nationwide Swedish Registry Data
Background: We investigated the impact of time to adjuvant chemotherapy (AC) on survival after surgical resection (<8 weeks or 8–16 weeks) for patients with non-small cell lung cancer (NSCLC) by applying a target-trial emulation. Material and Methods: We used Swedish population-based healthcare registries to emulate a hypothetical target trial, with treatment arms of ‘initiate AC <8 weeks postoper
